XM does not provide services to residents of the United States of America.
D
D

DiaSorin

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Diasorin rises on new product clearance from U.S. FDA

BUZZ-Diasorin rises on new product clearance from U.S. FDA ** Shares in Italy's DiaSorin DIAS.MI rise as much as 1.6% after the medical diagnostic group obtained clearance for its new product Liaison Plex Yeast Blood Culture Assay from the U.S. Food and Drug Administration. ** The product is the second multiplexing molecular diagnostic panel on the Liaison PLEX platform and allows the identification of 16 pathogens commonly associated with the presence of fungi in the blood.
D

Diasorin Obtains FDA 510(K) Clearance For Its Liaison Plex Yeast Blood Culture Assay

BRIEF-Diasorin Obtains FDA 510(K) Clearance For Its Liaison Plex Yeast Blood Culture Assay June 5 (Reuters) - DiaSorin SpA DIAS.MI : OBTAINS FDA 510(K) CLEARANCE FOR ITS LIAISON PLEX® YEAST BLOOD CULTURE ASSAY, FOLLOWING LIAISON PLEX SYSTEM CLEARANCE IN MARCH Further company coverage: DIAS.MI (Gdansk Newsroom)
D

Eiffage, Quilter, Ricardo

EUROPE RESEARCH ROUNDUP-Eiffage, Quilter, Ricardo June 3 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Eiffage, Quilter and Ricardo, on Monday. HIGHLIGHTS * Acciona Energia ANE.MC : Morgan Stanley raises to equalweight from underweight * Eiffage FOUG.PA : Goldman Sachs raises to buy from neutral * Quilter Plc QLT.L : JP Morgan raises to overweight from neutral * Ricardo Plc RCDO.L : Berenberg raises to buy from hold * St.
B
C
C
E
H
H
I
I
J
P
P
R
S
V
D
L
N

ABB Ltd, Capital & Regional Plc, Neste Oyj

EUROPE RESEARCH ROUNDUP- ABB Ltd, Capital & Regional Plc, Neste Oyj May 15 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including ABB Ltd, Capital & Regional Plc and Neste Oyj, on Wednesday. HIGHLIGHTS * ABB Ltd ABBN.S : TD Cowen raises target price to CHF 46 from CHF 38 * Capital & Regional Plc CAL.L : Berenberg cuts target price to 65p from 68p * Hannover Re HNRGN.DE : HSBC raises target price to EUR 235 from EUR 225 * Neste Oyj NESTE.H
A
A
A
B
B
C
C
D
E
E
G
H
N
A
D

European shares end flat as investors await for inflation test

UPDATE 2-European shares end flat as investors await for inflation test For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Maersk shares surge fuelled by soaring freight rates OX2 jumps 40% after cash offer from EQT Updated at 1609 GMT By Ankika Biswas and Johann M Cherian May 13 (Reuters) - Europe's STOXX 600 closed flat on Monday, as investors geared up for a slew of economic data from the euro zone and a key U.S.
A
A
C
M
D
E
F
U
G

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.